Pharmasurgics Ab

Pharmasurgics to Begin Phase II Clinical Trial for Prevention of Post-Surgical Adhesions

Older News

GOTHENBURG, Sweden, December 3 - Pharmasurgics AB - part of the Karolinska Development dermatology and wound healing company "Pergamum" - today announced that Pharmasurgics has received approval from the Swedish Medical Products Agency to begin a Phase II clinical trial.

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy